SEC Filings

Filing date	Form	Description	Filing Group	View
January 13, 2023	CORRESP	CORRESP	Other	View HTML 0001104659-23-003637.pdf 0001104659-23-003637.rtf
January 6, 2023	UPLOAD	UPLOAD	Other	View HTML 0000000000-23-000192.pdf 0000000000-23-000192.rtf
December 28, 2022	F-4	Registration statement for foreign private issuers issued in certain business transactions	Registration Statements	View HTML 0001104659-22-130315.pdf 0001104659-22-130315.rtf 0001104659-22-130315.xls
December 28, 2022	CORRESP	CORRESP	Other	View HTML 0001104659-22-130318.pdf 0001104659-22-130318.rtf
December 16, 2022	UPLOAD	UPLOAD	Other	View HTML 0000000000-22-013608.pdf 0000000000-22-013608.rtf
December 7, 2022	DRS/A	mendment to a previously filed DRS	Registration Statements	View HTML 0001104659-22-125040.pdf 0001104659-22-125040.rtf 0001104659-22-125040.xls
December 7, 2022	DRSLTR	Correspondence Related to Draft Registration Statement		View HTML 0001104659-22-125043.pdf 0001104659-22-125043.rtf
November 23, 2022	UPLOAD	UPLOAD	Other	View HTML 0000000000-22-012737.pdf 0000000000-22-012737.rtf
November 14, 2022	DRS/A	mendment to a previously filed DRS	Registration Statements	View HTML 0001104659-22-118284.pdf 0001104659-22-118284.rtf 0001104659-22-118284.xls
November 14, 2022	DRSLTR	Correspondence Related to Draft Registration Statement		View HTML 0001104659-22-118287.pdf 0001104659-22-118287.rtf 0001104659-22-118287.xls

Data provided by Kaleidoscope.

Print Page

Email Alerts

RSS Feeds

Contact IR

Site Map Terms of Use Privacy

Contact Info

LakeShore Biopharma, Ltd.

11 Firstfield Road Suite A
Gaithersburg, Maryland 20878 USA

Tel: +86 (10) 61253627

ir@lakeshorebio.com